Injectable Steroids
Kalpa Pharmaceuticals
Cutaxyl 150 mg
Product Information Compound Details
Active Formula Cut Stack Blend
150 mg/mLDrostanolone Propionate 50 mg
Testosterone Propionate 50 mg
Trenbolone Acetate 50 mg
Total Strength 150 mg/mL
Package 10 mL Vial 1,500 mg total labeled content
Form Oil-Based Injectable
Formula 3-Compound Cutting Blend
Drug Class Androgen & Anabolic Steroid
Manufacturer Kalpa Pharmaceuticals
$121.00
Shipping :
International
U.S. Domestic
Out of stock
- Overview
- Profile
- Usage
- Safety
- Shipping
- Storage
- FAQ
- Reviews
Product Overview
Cutaxyl 150 mg by Kalpa Pharmaceuticals
Cutaxyl 150 mg is an oil-based multi-compound cutting blend manufactured by Kalpa Pharmaceuticals and dosed at 150 mg/mL in a 10 mL vial.
Cut Stack Blend Injectable
Cutaxyl 150 mg is an injectable anabolic-androgenic steroid blend containing three short-acting compounds: drostanolone propionate (Masteron), testosterone propionate, and trenbolone acetate. Each component is dosed at 50 mg/mL, giving a total of 150 mg/mL. The blend combines a hardening agent, a testosterone base, and a potent anabolic in a single injection.
The rationale behind a cut stack blend is to combine compounds that are commonly referenced together in non-medical cutting phases. Drostanolone propionate is typically referenced for its hardening and cosmetic effects, testosterone propionate provides a short-acting testosterone base, and trenbolone acetate is a potent anabolic commonly referenced for strength and lean mass retention during caloric restriction.
All three components are short-acting propionate or acetate esters, which means the blend is typically referenced as being administered frequently. Testosterone supports muscle protein synthesis, recovery, strength, and sexual function. When these compounds are used at supraphysiologic levels for physique or performance enhancement, the potential for adverse effects also increases and such use falls outside approved medical indications.
Key Benefits of Cutaxyl 150 mg
- Three short-acting compounds combined in a single injectable
- Combines a hardening agent, testosterone base, and potent anabolic
- Short propionate/acetate esters for rapid onset and clearance
- Commonly referenced in non-medical cutting phase protocols
- MCT oil carrier for smooth, consistent formulation
Carrier Oil
MCT Oil Formulation
Cutaxyl 150 mg uses MCT oil as its carrier oil, providing the oil base for the three-compound cutting blend.
Product Profile
Cut Stack Blend Profile
Cutaxyl 150 mg is a three-compound cutting blend built around short-acting esters. Its multi-compound composition distinguishes it from single-substance injectables.
Three-Compound Cutting Blend
Each of the three compounds in Cutaxyl 150 mg contributes a distinct property to the blend. Drostanolone propionate is a non-aromatizing compound commonly referenced for its hardening effect and cosmetic appearance. Testosterone propionate is a short-acting testosterone ester that provides a base level of testosterone. Trenbolone acetate is a potent anabolic commonly referenced for strength and lean mass retention.
All three compounds use short esters (propionate and acetate), which means they are released relatively rapidly after administration and require more frequent injection than longer-ester preparations. This gives the blend a rapid onset and rapid clearance profile.
These characteristics explain why cut stack blends are commonly referenced in non-medical bodybuilding settings where a combination of hardening, testosterone support, and potent anabolic activity is desired from a single injection.
Release Profile
Rapid, Short-Duration Release
All three compounds in Cutaxyl 150 mg use short esters. Drostanolone propionate, testosterone propionate, and trenbolone acetate each release rapidly after injection and have correspondingly brief durations of activity. This profile contrasts with longer-ester preparations such as testosterone cypionate or enanthate.
Cutaxyl 150 mg vs Other Kalpa Preparations
Kalpa Pharmaceuticals offers several injectable blends and single-compound formulations. The main practical distinctions between these preparations involve the compounds used, the ester composition, and the intended use context.
For a milder cutting blend, Masteroxyl 100 provides drostanolone propionate as a standalone compound. For a heavier cutting mix, Trenboxyl Acetate provides trenbolone acetate on its own. For a broader cutting combination that includes multiple trenbolone esters, Trinaxyl 150 mg combines trenbolone acetate, enanthate, and hexahydrobenzylcarbonate. For users who prefer a testosterone base as a standalone, Testoxyl Propionate provides testosterone propionate.
Dosage & Usage
Cutaxyl 150 mg Dosage & Usage
The information below is provided for educational reference only. Cutaxyl 150 mg contains prescription-class androgens; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.
Typical Dosage Ranges
In non-medical bodybuilding settings, cut stack blends containing trenbolone acetate are typically referenced at conservative total weekly volumes because of the potency of the trenbolone component. Cutaxyl 150 mg is commonly referenced in the range of 150–300 mg per week, typically administered as 50–100 mg every other day, though such use falls outside approved medical indications. The limiting factor in this blend is the trenbolone acetate content, which is dosed at 50 mg/mL.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Non-medical cutting (beginner to blend) | 50 mg per injection | Every other day |
| Non-medical cutting (experienced) | 100 mg per injection | Every other day |
| Stacking with additional compounds | Typically limited by trenbolone content | Per cycle protocol |
Stacking & Cycle Considerations
Cut stacks containing trenbolone acetate are typically referenced as being stacked with mild oral compounds or additional testosterone during non-medical cutting phases. Because the blend already contains testosterone propionate, additional testosterone is not always required. Users sometimes reference Stanoxyl 10 or Oxandroxyl 10 as oral additions to a cut stack in non-medical contexts. Cycle structure, duration and support compounds should be considered in the context of individual experience, health status and bloodwork where possible.
Because all three compounds use short esters, Cutaxyl 150 mg requires more frequent administration than longer-ester preparations. Users typically reference daily or every-other-day injection schedules to maintain stable blood levels.
Managing Side Effects
The three compounds in Cutaxyl 150 mg have different side-effect profiles. Testosterone propionate aromatizes, which can contribute to water retention and estrogenic effects. Aromatase inhibitors such as Arimixyl are commonly referenced in this context. Drostanolone propionate does not aromatize. Trenbolone acetate does not aromatize but is associated with additional considerations including night sweats, insomnia, and blood pressure effects.
Because trenbolone is included in the blend, users commonly reference the use of cabergoline-like compounds for prolactin-related considerations, and monitor cardiovascular markers more closely than they might with milder compounds. Cholesterol, hematocrit and blood pressure should be monitored during use.
Post-Cycle Therapy (PCT)
After completing a cycle with Cutaxyl 150 mg, post-cycle therapy is commonly recommended to help restore endogenous testosterone production and support hormonal recovery. Because the blend contains trenbolone, some users extend the period between the last injection and the start of PCT to allow the short-acting esters to clear. Agents such as Clomixyl or Nolvaxyl are commonly referenced for PCT.
PCT protocols vary based on cycle length, compounds used and individual factors. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Important
Individual Response Varies
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Safety & Information
Cut Stack Blend Safety Information
Cutaxyl 150 mg contains three anabolic-androgenic steroids including trenbolone acetate. These compounds can affect hormonal, reproductive, cardiovascular and hematologic function. Non-medical use falls outside approved indications and carries additional health risks.
Important Safety Information
Trenbolone acetate, one of the three compounds in Cutaxyl 150 mg, is not FDA-approved for human use in the United States. Drostanolone propionate is likewise not FDA-approved for human use. Testosterone propionate is not currently marketed as an FDA-approved human product. The blend as a whole has not undergone the clinical trial process required for human pharmaceutical approval.
Use of these compounds at supraphysiologic levels for bodybuilding or performance enhancement falls outside any approved indication and can increase exposure to androgen-related adverse effects.
Important
Non-Medical Use of a Multi-Compound Blend
Cutaxyl 150 mg combines three separate anabolic compounds, two of which are not FDA-approved for human use. Non-medical use of such blends carries additional risks compared to single-compound preparations. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual.
Potential Adverse Effects
All three compounds in the blend can suppress endogenous testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis. This can lead to reduced testicular function and impaired fertility.
Trenbolone acetate is associated with cardiovascular effects including elevated blood pressure and changes in lipid profile. Night sweats, insomnia, and mood-related effects are also commonly referenced. Trenbolone does not aromatize but may be associated with prolactin-related effects in some users.
Testosterone propionate aromatizes, which can contribute to water retention, gynecomastia and elevated blood pressure in susceptible individuals. Drostanolone propionate does not aromatize but may contribute to androgenic side effects such as hair loss in predisposed individuals.
Conditions Requiring Medical Evaluation
Anabolic steroid use is not appropriate for everyone. Medical guidelines identify circumstances in which androgen therapy should be avoided or carefully evaluated, including known or suspected prostate or male breast cancer, elevated hematocrit, certain cardiovascular conditions, thrombophilia and near-term fertility plans.
Existing cardiovascular disease, abnormal blood counts, and other medical conditions should be discussed with a qualified healthcare professional before any androgen use is considered.
Monitoring Considerations
Medically supervised androgen therapy typically involves follow-up assessment to evaluate treatment response, adverse effects and relevant laboratory markers. For Cutaxyl 150 mg, monitoring would typically include testosterone concentrations, hematocrit, lipid profile, and blood pressure, with additional attention to cardiovascular markers given the trenbolone content.
For non-medical use of Cutaxyl 150 mg, such monitoring is not typically performed, which increases the risk of unrecognized adverse effects.
Product Care
Storage & Handling
Keep the vial securely stored and protected from conditions that could compromise the product or container. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
Cutaxyl 150 mg is supplied through the official Kalpa Pharmaceuticals distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Kalpa Pharmaceuticals distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Cutaxyl 150 mg product, use the security code on the vial label and cross-check it on the Kalpa official site. Official Kalpa Pharmaceuticals presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Cutaxyl 150 mg Storage
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Recommended Conditions
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Quick Reference
Do & Don't
- Do store at 15–25°C
- Do keep in original packaging
- Do inspect before each use
- Don't freeze the vial
- Don't expose to direct sunlight
- Don't use if solution looks abnormal
Frequently Asked Questions
Cutaxyl 150 mg FAQ
Answers to common questions about Cutaxyl 150 mg, the cut stack blend, its three active compounds, release characteristics, and how it compares to other preparations.
What is Cutaxyl 150 mg used for?
Cutaxyl 150 mg contains a blend of drostanolone propionate, testosterone propionate, and trenbolone acetate. In non-medical bodybuilding settings it is commonly referenced in cutting phases for its combination of hardening, testosterone base, and potent anabolic activity, though such use falls outside approved medical indications.
How often should Cutaxyl 150 mg be injected?
All three compounds in Cutaxyl 150 mg use short-acting esters (propionate and acetate). Because of this, the blend is typically referenced as being administered every other day or, in some protocols, daily. This frequency is a practical consideration for maintaining stable blood levels with short-ester compounds.
Does Cutaxyl 150 mg require PCT?
What do the compounds in Cutaxyl 150 mg do?
Drostanolone propionate is a non-aromatizing compound commonly referenced for hardening and cosmetic effects. Testosterone propionate is a short-acting testosterone ester that provides a base level of testosterone. Trenbolone acetate is a potent anabolic commonly referenced for strength and lean mass retention during caloric restriction.
All three compounds ultimately promote anabolism in skeletal muscle through androgen receptor binding. Non-medical use for bodybuilding falls outside approved indications.
How long does Cutaxyl 150 mg take to work?
All three compounds in Cutaxyl 150 mg use short-acting esters (propionate and acetate), so circulating levels rise relatively quickly after administration compared to longer-ester preparations. Effects are correspondingly shorter-lived between injections.
The time required to notice a change depends on what is being evaluated, the individual's starting hormone levels, treatment circumstances and other biological factors.
Is a cut stack the best option for cutting?
There is no single best option for cutting. Cut stack blends such as Cutaxyl 150 mg combine multiple compounds in a single injection, which some users prefer for convenience. Other users reference single-compound approaches during cutting phases.
Kalpa Pharmaceuticals offers several products that are commonly referenced in this context, including Trenboxyl Acetate as a standalone trenbolone acetate preparation, Masteroxyl 100 as a standalone drostanolone propionate, and Stanoxyl 10 as an oral cutting compound. The appropriate choice depends on the circumstances in which the compounds are being used.
What is the difference between Cutaxyl 150 mg and Trinaxyl 150 mg?
Both are 150 mg/mL cutting blends, but their compositions differ. Cutaxyl 150 mg contains drostanolone propionate, testosterone propionate, and trenbolone acetate — one compound from three different families. Trinaxyl 150 mg contains three trenbolone esters (acetate, enanthate, and hexahydrobenzylcarbonate) — three variants of the same compound.
The choice between them depends on whether the user wants a multi-compound blend or a multi-ester trenbolone formulation.
Is 150 mg of Cutaxyl a lot?
A milligram amount cannot be classified as appropriate or excessive without considering the medical indication, individual response, laboratory results, treatment schedule and the specific product being used. Cutaxyl 150 mg is a 150 mg/mL blend, meaning each mL delivers 50 mg of each of the three compounds.
It is also important to distinguish a dose in milligrams from a product's concentration in mg/mL. The blend is labeled at 150 mg/mL total, but that concentration does not by itself specify how much should be administered.
What strength is Cutaxyl 150 mg?
Cutaxyl 150 mg is labeled at 150 mg total per mL, composed of 50 mg drostanolone propionate, 50 mg testosterone propionate, and 50 mg trenbolone acetate per mL. It is supplied in a 10 mL vial, giving 1,500 mg of total labeled content per vial.
Can Cutaxyl 150 mg be used by beginners?
Cutaxyl 150 mg contains trenbolone acetate, which is commonly referenced as one of the more potent anabolic compounds. In non-medical contexts, trenbolone-containing blends are typically referenced by experienced users rather than beginners.
The potency of the trenbolone component is a significant consideration when evaluating whether this blend is appropriate for a given individual. Any such decision should be made with reference to experience level and, where possible, medical guidance.
Why is Cutaxyl 150 mg dosed at 150 mg/mL with three compounds?
A cut stack blend combines three compounds in a single injection to reduce injection volume and simplify administration for users who want to use these compounds together. Rather than drawing from three separate vials, a user injects a single blend.
Each compound in Cutaxyl 150 mg is dosed at 50 mg/mL, giving a total of 150 mg/mL. This is a practical formulation choice for a multi-compound blend.
Cutaxyl 150 mg Reviews
E***c.
May 29, 2019
May 29, 2019
Been using it just over 2 weeks. Muscles hardening up with amazing strength and aggression. Typical tren sides like insomnia, night sweats with stiff dry joints. It's my second run with tren. Ran Tren in Cutaxyl stack last year. Libido is high, strength is rising and veins are showing.
This is a perfect stack to get shredded for summer. It has all what's needed to cut down body fat percentage.
KalpaPharm.com is my fav source. Will be ordering more
G***e.
April 12, 2019
April 12, 2019
By far one of the strongest and effective cutting agent I have ever used. Insane energy, focus and a lot of strength. It wasn't bad on the pip at all. Insane libido. Noticed hair thinning and other sides such as night sweats, acne, zits and oily skin. Aggression appeared in no time and joints began to hurt too.
Please log in to write Cutaxyl 150 mg review.
Related Offers
Lab Tested
Kalpa Pharmaceuticals LTD, India
Product Information Compound Details
Active Substance Testosterone Cypionate Long-acting testosterone ester
250 mg/mLStrength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable
Estimated Half-Life Approximately 8 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer Kalpa Pharmaceuticals
$101.00
Lab Tested
Kalpa Pharmaceuticals LTD, India
Product Information Compound Details
Active Substance Testosterone Enanthate Long-acting testosterone ester
250 mg/mLStrength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable
Estimated Half-Life Approximately 7–8 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer Kalpa Pharmaceuticals
Kalpa Pharmaceuticals LTD, India
Product Information
Compound Details
Active Substance
Clomiphene Citrate
Selective estrogen receptor modulator
50 mg/tablet
Strength
50 mg/tablet
Package
30 or 100 Tablets
1,500 mg or 5,000 mg total labeled content
Form
Oral Tablet
Half-Life
Approximately 5–7 Days
Drug Class
Selective Estrogen Receptor Modulator
Manufacturer
Kalpa Pharmaceuticals
Kalpa Pharmaceuticals LTD, India
Product Information
Compound Details
Active Substance
Tamoxifen Citrate
Selective estrogen receptor modulator
20 mg/tablet
Strength
20 mg/tablet
Package
30 or 100 Tablets
600 mg or 2,000 mg total labeled content
Form
Oral Tablet
Half-Life
Approximately 5–7 Days
Drug Class
Selective Estrogen Receptor Modulator
Manufacturer
Kalpa Pharmaceuticals
March 3, 2021
Started at 1.2cc eod a few weeks ago, to test the tren. Now blasting 2cc eod. Loving it. Just rotate sites and plan work outs around injection days.